Caffeinated energy drinks: adverse event reports to the US Food and Drug Administration and the National Poison Data System, 2008 to 2015
| Autor: | Beverly J Wolpert, Olivia E. Jones, Cecile Punzalan, Peter Lurie, André O. Markon |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
Male medicine.medical_specialty Poison Control Centers Adolescent Drug-Related Side Effects and Adverse Reactions Medicine (miscellaneous) Poison control Suicide prevention Occupational safety and health Young Adult 03 medical and health sciences Adverse Event Reporting System 0404 agricultural biotechnology 0302 clinical medicine Caffeine Environmental health Injury prevention medicine Adverse Drug Reaction Reporting Systems Energy Drinks Humans 030212 general & internal medicine Child Adverse effect Aged Aged 80 and over Nutrition and Dietetics United States Food and Drug Administration business.industry Public health Public Health Environmental and Occupational Health Human factors and ergonomics 04 agricultural and veterinary sciences Middle Aged 040401 food science United States Cross-Sectional Studies Central Nervous System Stimulants Female business Research Paper |
| Zdroj: | Public Health Nutr |
| ISSN: | 1475-2727 1368-9800 |
| DOI: | 10.1017/s1368980019001605 |
| Popis: | Objective:To describe and compare caffeinated energy drink adverse event (AE) report/exposure call data from the US Food and Drug Administration Center for Food Safety and Applied Nutrition’s Adverse Event Reporting System (CAERS) and the American Association of Poison Control Centers’ National Poison Data System (NPDS).Design:Cross-sectional.Setting:Data were evaluated from US-based CAERS reports and NPDS exposure calls, including report/exposure call year, age, sex, location, single v. multiple product consumption, outcome, symptom, intentionality (NPDS only), report type, product name (CAERS only).Participants:The analysis defined participants (cases) by the number of caffeinated energy drink products indicated in each AE report or exposure call. Single product cases included 357 from CAERS and 12 822 from NPDS; multiple product cases included 153 from CAERS and 931 from NPDS.Results:CAERS v. NPDS single product cases were older and more frequently indicated serious symptoms. Multiple v. single product consumers were older in both. In CAERS, unlike NPDS, most multiple product consumers were female. CAERS single v. multiple product reports cited higher proportions of life-threatening events, but less often indicated hospitalization and serious events. NPDS multiple v. single product cases involved fewer ≤5-year-olds and were more often intentional.Conclusions:Despite limitations, both data sources contribute to post-market surveillance and improve understanding of public health concerns. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|